Overview

Clinical Efficacy and Safety Evaluation of Nicergoline in Patients With Neurological Dysphagia.

Status:
Not yet recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
Dysphagia is a complication in patient with stroke, Parkinson's disease or dementia that can lead to aspiration pneumonia. This study aimed to investigate dysphagia improvement after treatment with nicergoline low dose and high dose, the relationship between nicergoline dose and clinical improvements, side effect of nicergoline and simulation optimal nicergoline dose in dysphagia improvement.
Phase:
Phase 3
Details
Lead Sponsor:
Phramongkutklao College of Medicine and Hospital
Collaborator:
Silpakorn University Faculty of Pharmacy
Treatments:
Nicergoline